Lack of Association of Generic Brittle Status with Genetics and Physiologic Measures in Patients with Epilepsy.

Questions from neurologists and patients about generics is frequently based on applicability of generic drug standards to individual subjects. However, findings here in patients with epilepsy did not uncover genetic or physiologic reasons that explained which patients were GB and which were not GB.